The use of ACTEMRA in COVID-19 pneumonia patients has not been approved by the FDA.

Genentech Medical Affairs is providing healthcare providers with up-to-date information on ACTEMRA to enable physicians to make informed individual patient treatment decisions.

Genentech Medical Responses to ACTEMRA in COVID-19 Inquiries

For additional online medical resources, to submit a question, or to virtually connect with a Genentech Medical Science Liaison (MSL), please view